Refine
Has Fulltext
- yes (18)
Is part of the Bibliography
- yes (18)
Year of publication
Document Type
- Journal article (18)
Language
- English (18)
Keywords
- breast cancer (4)
- CD39 (2)
- CD73 (2)
- Parkinson’s disease (2)
- T cells (2)
- adenosine (2)
- expression (2)
- immune escape (2)
- immune response (2)
- neurodegeneration (2)
- ovarian cancer (2)
- trastuzumab (2)
- ADCC (1)
- B7-H1 (1)
- Coronavirus Disease 2019 (1)
- HER2 conversion (1)
- HER2 targeted therapy (1)
- HER2-low (1)
- HLA-G gene (1)
- Hautkrebs (1)
- Krebs <Medizin> (1)
- PC-1 blockade (1)
- PD-1 (1)
- PD-L1 (1)
- Severe Acute Respiratory Syndrome Coronavirus 2 (1)
- T lymphocytes (1)
- acute respiratory distress syndrome (1)
- animal models (1)
- bioinformatics (1)
- biomarker (1)
- bioreactor culture (1)
- blastocysts (1)
- brain development (1)
- brain metastases (1)
- cancer microenvironment (1)
- cancer stem cell immunology (1)
- cancer stem cells (1)
- cell lung cancer (1)
- chlamydia trachomatis (1)
- combinatorial drug predictions (1)
- cytokines (1)
- disease (1)
- diseases of the nervous system (1)
- gene (1)
- growth differentiation factor 15 (1)
- histopathology (1)
- immunoresistance (1)
- immunosurveillance (1)
- immunotherapies (1)
- immunotherapy (1)
- in vitro (1)
- inflammation (1)
- inflammatory cascades (1)
- invasiveness (1)
- latency (1)
- lines (1)
- lung-cancer (1)
- mammography (1)
- melanoma (1)
- mhc molecules (1)
- miRNA (1)
- microarray (1)
- microglia (1)
- microna profiles (1)
- modular tumor tissue models (1)
- multiple sclerosis (1)
- nervous system (1)
- neuroimmunology (1)
- neuroinflammation (1)
- neurological disorders (1)
- peripheral blood (1)
- pertuzumab (1)
- safety (1)
- serum (1)
- signature (1)
- stem/progenitor cells (1)
- survival (1)
- trastuzumab deruxtecan (1)
- tumor (1)
- tumor associated macrophages (1)
- tumor dormancy (1)
- tumor immune escape (1)
- tumor immunology (1)
- tumor immunosurveillance (1)
- tumor size (1)
- tumor stem cells (1)
- tumor-infiltrating lymphocytes (1)
- tumor-propagating cells (1)
- tumour immunology (1)
- ultrasound (1)
- viral load (1)
- α-synuclein-specific T cells (1)
Institute
- Frauenklinik und Poliklinik (14)
- Institut für Virologie und Immunbiologie (4)
- Kinderklinik und Poliklinik (3)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (3)
- Neurologische Klinik und Poliklinik (3)
- Theodor-Boveri-Institut für Biowissenschaften (3)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (2)
- Medizinische Klinik und Poliklinik II (2)
- Pathologisches Institut (2)
- Institut für Hygiene und Mikrobiologie (1)
Background
Ovarian cancer (OvCA) tissues show abundant expression of the ectonucleotidases CD39 and CD73 which generate immunomodulatory adenosine, thereby inhibiting cytotoxic lymphocytes. Little, however, is known about the effect of adenosine on myeloid cells. Considering that tumor associated macrophages (TAM) and myeloid-derived suppressor cells (MDSC) constitute up to 20 % of OvCA tissue, we investigated the effect of adenosine on myeloid cells and explored a possible contribution of myeloid cells to adenosine generation in vitro and ex vivo.
Methods
Monocytes were used as human blood-derived myeloid cells. After co-incubation with SK-OV-3 or OAW-42 OvCA cells, monocyte migration was determined in transwell assays. For conversion into M2-polarized “TAM-like” macrophages, monocytes were co-incubated with OAW-42 cells. Ex vivo TAMs were obtained from OvCA ascites. Macrophage phenotypes were investigated by intracellular staining for IL-10 and IL-12. CD39 and CD73 expression were assessed by FACS analysis both on in vitro-induced TAM-like macrophages and on ascites-derived ex situ-TAMs. Myeloid cells in solid tumor tissue were analyzed by immunohistochemistry. Generation of biologically active adenosine by TAM-like macrophages was measured in luciferase-based reporter assays. Functional effects of adenosine were investigated in proliferation-experiments with CD4+ T cells and specific inhibitors.
Results
When CD39 or CD73 activity on OvCA cells were blocked, the migration of monocytes towards OvCA cells was significantly decreased. In vivo, myeloid cells in solid ovarian cancer tissue were found to express CD39 whereas CD73 was mainly detected on stromal fibroblasts. Ex situ-TAMs and in vitro differentiated TAM-like cells, however, upregulated the expression of CD39 and CD73 compared to monocytes or M1 macrophages. Expression of ectonucleotidases also translated into increased levels of biologically active adenosine. Accordingly, co-incubation with these TAMs suppressed CD4+ T cell proliferation which could be rescued via blockade of CD39 or CD73.
Conclusion
Adenosine generated by OvCA cells likely contributes to the recruitment of TAMs which further amplify adenosine-dependent immunosuppression via additional ectonucleotidase activity. In solid ovarian cancer tissue, TAMs express CD39 while CD73 is found on stromal fibroblasts. Accordingly, small molecule inhibitors of CD39 or CD73 could improve immune responses in ovarian cancer.